Clinical Trial Update: The OPENS Trial: Offering Women PrEP (Aim 2) [NA]

View source ↗

Summary

Update on the OPENS trial evaluating HIV pre-exposure prophylaxis in women, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Sexually Transmitted Infections

Snippet

Sponsor: University of California, San Francisco | Conditions: Human Immunodeficiency Virus, Human Immunodeficiency Virus Transmission | NA | Status: COMPLETED